Peel Hunt Reaffirms “Under Review” Rating for Chemring Group (CHG)

Share on StockTwits

Peel Hunt reissued their under review rating on shares of Chemring Group (LON:CHG) in a report released on Wednesday morning. They currently have a GBX 240 ($3.10) price objective on the stock.

A number of other brokerages also recently issued reports on CHG. Barclays raised shares of Chemring Group to an overweight rating and boosted their price objective for the company from GBX 205 ($2.64) to GBX 266 ($3.43) in a research report on Tuesday, July 10th. Liberum Capital reissued a buy rating on shares of Chemring Group in a research report on Friday, May 11th. One research analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. The stock presently has a consensus rating of Buy and an average target price of GBX 231.20 ($2.98).

Shares of Chemring Group stock opened at GBX 220 ($2.84) on Wednesday. Chemring Group has a 12-month low of GBX 162 ($2.09) and a 12-month high of GBX 207.50 ($2.68).

The firm also recently announced a dividend, which will be paid on Friday, September 14th. Stockholders of record on Thursday, August 30th will be given a GBX 1.10 ($0.01) dividend. This represents a dividend yield of 0.49%. The ex-dividend date of this dividend is Thursday, August 30th.

Chemring Group Company Profile

Chemring Group PLC develops, manufactures, and sells protection solutions for defense and security markets worldwide. It operates through three segments: Countermeasures, Sensors & Electronics, and Energetic Systems. The Countermeasures segment designs, develops, manufactures, and sells expendable countermeasures for protecting air, sea, and land platforms; and land?based electronic warfare equipment.

Featured Story: How are Outstanding Shares Different from Authorized Shares?

Receive News & Ratings for Chemring Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemring Group and related companies with's FREE daily email newsletter.

Leave a Reply